RIME or erythema multiforme major? Diagnostic classification before attributing clinical response to IVIg
Clicks: 2
ID: 323205
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #168 of 176 articles by views in clinical and experimental dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 176 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This letter questions whether some IVIg-treated cases classified as erythema multiforme major may instead represent reactive infectious mucocutaneous eruption. Diagnostic heterogeneity, concomitant therapies and inconsistencies in the reported data limit attribution of clinical improvement specifically to IVIg, underscoring the need for explicit phenotypic classification before therapeutic inference.
| Reference Key |
openalex_W7172134486
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Fatih Kaplan |
| Journal | clinical and experimental dermatology |
| Year | 2026 |
| DOI |
10.1093/ced/llag340
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.